Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
IC-data over patiënten met longabcessen
apr 2024 | Bacteriële infecties, Schimmelinfecties